What is HALO's EasyStocksAI score?

Halozyme Therapeutics Inc (HALO) scores 60 out of 100 on EasyStocksAI's Graham-inspired scoring system. Breakdown: Total Shareholder Yield: 4/25, Return Consistency: 0/25, Return Growth: 0/25, Payment Regularity: 0/25, Revenue Growth: 10/25, Earnings Growth: 6/25, Margin Trend: 2/25, Capital Efficiency: 3/25, P/E vs Sector: 9/25, Graham Ratio Trend: 0/25, Price Stability: 0/25, Earnings Yield: 1/25, 10Y SPY Outperformance: 12/25, 10Y Sector Outperformance: 10/25, Crisis Resilience: 11/25.

Does HALO pay dividends?

Halozyme Therapeutics Inc does not currently pay a regular dividend.

Halozyme Therapeutics Inc's Graham Number is 4.88. The current price of 63.56 is above the Graham Number.

How does HALO compare to the Health Care sector?

Halozyme Therapeutics Inc has a P/E ratio of 24.87 in the Health Care sector.

insights

EasyStocksAI

HAL

HALO

Halozyme Therapeutics Inc

$63.56 arrow_downward $2.92 (4.39%)

AI Score

N/A

Loading chart…

Loading chart...

analytics Financial Highlights

P/E Ratio 24.87

Dividend Yield 0.00%

Graham Number 4.88

Market Cap $7.9B

Div. Increase Years 0

Continuous Years 0

Crises Survived 3

speed Performance Benchmarks

vs S&P 500 (10Y) +289.75%

vs Sector (10Y) +491.28%

speed Market Sentiment

Neutral

OVERALL MARKET CONFIDENCE

show_chart Trend Analysis

Primary Trend

▴ Uptrend

Secondary Trend Bearish

Warning Price dropped below 20-day MA

MA 20

70.00

MA 50

72.16

MA 200

66.66

analytics Sector Comparison (Health Care)

P/E Ratio —

Graham Ratio —

Track HALO and 1,000+ stocks for free

Get scores, alerts, and portfolio tracking — no credit card required.

Start Free →